| 2024-02-01 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 66,666 1.2878% | $0.30 | $20,000 | -9.34% | ||
| 2023-08-22 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 27,000 0.4674% | $1.27 | $34,177 | -67.7% | ||
| 2023-04-17 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 3,100 0.1892% | $3.20 | $9,920 | -42% | ||
| 2021-12-06 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 5,000 0.0182% | $0.94 | $4,702 | -70.09% | ||
| 2021-11-19 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 4,500 0.0166% | $1.15 | $5,192 | -74.58% | ||
| 2020-08-24 | CNS Pharmaceuticals, Inc. CNSP | Chief Financial Officer | 142,000 0.8136% | $2.04 | $289,680 | -7.87% | ||
| 2017-08-14 | InfuSystem Holdings, Inc. INFU | CFO (interim) | 15,800 0.0677% | $1.90 | $30,020 | +21.03% |